Highlights
NASDAQ: CTIC       Cti Biopharm Corp
Last Price Today's Change   Day's Range   Trading Volume
1.28   -0.06 (4.48%)  1.271 - 1.345  249,500

Overview

 
Avg Volume (4 weeks):290,211
4 Weeks Range:1.271 - 1.72
4 Weeks Price Volatility (%):
2.00%
52 Weeks Range:0.631 - 1.93
52 Weeks Price Volatility (%):
49.96%
Average Price Target: 3.00
Price Target Upside/Downside: +1.72

Headlines



No recent Headlines for this stock.


Business Background

CTI Biopharma Corp is a biopharmaceutical company focused on the development and commercialization of less toxic, more effective cancer therapies. The company's therapeutic area is blood-related cancers. One of the company's products, Pixantrone (PIXUVRI), received conditional marketing approval in the EU in 2012 to treat refractory aggressive B-cell non-Hodgkin lymphoma. Another product is Pacritinib, an oral tyrosine kinase inhibitor to treat mutations such as Janus associated kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3).

  Be the first to like this.
 


 

2885  5191  592  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.79-0.38 
 FCEL 2.22-0.66 
 CHK 0.593-0.004 
 AVP 5.60-0.05 
 GE 11.37-0.29 
 EEM 45.43+0.37 
 NTRP 1.42-0.03 
 SPY 331.34+0.04 
 FXI 43.47+0.48 
 GNPX 1.89+0.74 
Partners & Brokers